DNA SEQUENCER 96 CAPILLARIES: GENETICS, GENE THERAPY

DNA 测序仪 96 毛细血管:遗传学、基因治疗

基本信息

  • 批准号:
    7335293
  • 负责人:
  • 金额:
    $ 5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-04-15 至 2007-04-14
  • 项目状态:
    已结题

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Shared Instrumentation Grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the grant, which is not necessarily the institution for the investigator. DESCRIPTION (provided by applicant): ABI 48-capillary 3730 DNA Sequencer is the major sequencing instrument of the DNA Sequencing Facility at the University of Pennsylvania. This NCRR Shared Instrument Grant application requests funding for an upgrade of the 48-capillary Sequencer to 96-capillary 3730XL format to meet the increased demand for high throughput DNA sequencing at a reduced cost and faster turn-around time. The 3730 sequencer is currently used to provide institutional investigators reliable, long read, automated DNA sequencing, and microsatellite-based genotyping. These services are essential to investigators for various purposes including, but not limited to, searching for alterations in candidate genes that may be associated with the pathogenesis of disease including cancer and diabetes or studying the evolutionary significance of sequence variations found among various DNA repeat elements observed in the genome. The integrated service for DNA sequencing, genotyping, template preparation, and other molecular biological procedures enables this core to provide full support for molecular genetic investigations, from consultation in experimental design to bioinformatic support for analysis and interpretation of the acquired data. The DNA Sequencing Facility is a major research service at Penn as demonstrated by a steady increase (~25%) in the number of sequencing samples processed during last three years. The projected number in 2005 is 104,000. Recently, following the recommendation of the core advisory committee, the facility has introduced high throughput sequencing at a very affordable cost to meet the large scale sequencing requirements of the investigators mentioned in this application. As a result, the number of sequencing samples is now projected to increase by an additional 25% every year. The turnaround time is likely to be compromised with the existing capacity since, at present, the 48-capillary sequencer is being operated almost at full capacity. To keep pace with the latest growth in usage from the high volume users and maintain the current turnaround time of 24 hrs, we propose to upgrade to 96-capillary sequencer. The cost of this upgrade is about half the price of a new 48-capillary sequencer. This will double the capabilities for sequencing and genotyping and will lead to higher throughput, faster turnaround time, and a further lowering of cost that will be beneficial to the high volume users as well as to all NIH funded and other users at Penn.
该子项目是利用由NIH/NCRR资助的共享仪器赠款提供的资源的许多研究子项目之一。子项目和研究者(PI)可能从另一个NIH来源获得主要资金,因此可以在其他CRISP条目中表示。列出的机构是用于资助的,不一定是研究者的机构。描述(由申请人提供):ABI 48-毛细管3730 DNA测序仪是宾夕法尼亚大学DNA测序设施的主要测序仪器。该NCRR共享仪器拨款申请要求资助将48毛细管测序仪升级为96毛细管3730 XL格式,以满足对高通量DNA测序的需求,同时降低成本和缩短周转时间。3730测序仪目前用于为机构研究人员提供可靠的、长读段的自动DNA测序和基于微卫星的基因分型。这些服务对于研究人员来说是必不可少的,用于各种目的,包括但不限于寻找可能与疾病(包括癌症和糖尿病)发病机制相关的候选基因的改变,或研究基因组中观察到的各种DNA重复元件中发现的序列变异的进化意义。DNA测序、基因分型、模板制备和其他分子生物学程序的综合服务使该核心能够为分子遗传学研究提供全面支持,从实验设计咨询到分析和解释所获得数据的生物信息学支持。 DNA测序设施是宾夕法尼亚大学的一项主要研究服务,在过去三年中处理的测序样本数量稳步增加(约25%)。2005年的预计数字为104 000人。最近,根据核心咨询委员会的建议,该设施以非常实惠的成本引入了高通量测序,以满足本申请中提到的研究人员的大规模测序要求。因此,测序样本的数量预计每年将增加25%。周转时间很可能与现有的能力妥协,因为目前48毛细管测序仪几乎是满负荷运行的。为配合高使用量用户的最新使用增长,并维持目前24小时的周转时间,我们建议升级至96毛细管测序仪。这种升级的成本大约是新的48毛细管测序仪价格的一半。这将使测序和基因分型的能力加倍,并将导致更高的通量,更快的周转时间,以及进一步降低成本,这将有利于大批量用户以及所有NIH资助的用户和宾夕法尼亚大学的其他用户。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TAPAN GANGULY其他文献

TAPAN GANGULY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TAPAN GANGULY', 18)}}的其他基金

DNA SEQUENCER 96 CAPILLARIES: NOVEL VACCINES FOR SMALLPOX
DNA 测序仪 96 毛细血管:天花新型疫苗
  • 批准号:
    7335296
  • 财政年份:
    2006
  • 资助金额:
    $ 5万
  • 项目类别:
DNA SEQUENCER 96 CAPILLARIES: HIV GENOME, INTEGRATION, INFECTION
DNA 测序仪 96 毛细血管:HIV 基因组、整合、感染
  • 批准号:
    7335292
  • 财政年份:
    2006
  • 资助金额:
    $ 5万
  • 项目类别:
Upgrade of applied biosystems 3730 DNA sequencer from 48 to 96 capillaries
Applied Biosystems 3730 DNA 测序仪从 48 个毛细管升级到 96 个
  • 批准号:
    7046420
  • 财政年份:
    2006
  • 资助金额:
    $ 5万
  • 项目类别:
DNA SEQUENCER 96 CAPILLARIES:GENE THERAPY FOR CONGENITAL AMAUROSIS
DNA 测序仪 96 毛细血管:先天性黑蒙症的基因治疗
  • 批准号:
    7335295
  • 财政年份:
    2006
  • 资助金额:
    $ 5万
  • 项目类别:
DNA SEQUENCER 96 CAPILLARIES: RETINAL DEGENERATION, RETINITIS PIGMENTOSA
DNA 测序仪 96 毛细血管:视网膜变性、色素性视网膜炎
  • 批准号:
    7335294
  • 财政年份:
    2006
  • 资助金额:
    $ 5万
  • 项目类别:
Genomic Analysis Core
基因组分析核心
  • 批准号:
    10550261
  • 财政年份:
    1997
  • 资助金额:
    $ 5万
  • 项目类别:
Genomic Analysis Core
基因组分析核心
  • 批准号:
    10330982
  • 财政年份:
    1997
  • 资助金额:
    $ 5万
  • 项目类别:
Genomic Analysis Core
基因组分析核心
  • 批准号:
    10088762
  • 财政年份:
    1997
  • 资助金额:
    $ 5万
  • 项目类别:
Genomic Analysis Core
基因组分析核心
  • 批准号:
    9220734
  • 财政年份:
  • 资助金额:
    $ 5万
  • 项目类别:
Genomic Analysis Core
基因组分析核心
  • 批准号:
    8998400
  • 财政年份:
  • 资助金额:
    $ 5万
  • 项目类别:

相似海外基金

ANGPTL8: function and mechanism of action
ANGPTL8:功能和作用机制
  • 批准号:
    9381308
  • 财政年份:
    2017
  • 资助金额:
    $ 5万
  • 项目类别:
Relevance of the Route of Insulin Delivery to the Develpment of Hypoglycemia
胰岛素输送途径与低血糖发生的相关性
  • 批准号:
    8649470
  • 财政年份:
    2013
  • 资助金额:
    $ 5万
  • 项目类别:
Metformin and Muscle in Insulin-resistant Older Veterans
二甲双胍与胰岛素抵抗老年退伍军人的肌肉
  • 批准号:
    8441203
  • 财政年份:
    2013
  • 资助金额:
    $ 5万
  • 项目类别:
Metformin and Muscle in Insulin-resistant Older Veterans
二甲双胍与胰岛素抵抗老年退伍军人的肌肉
  • 批准号:
    8659189
  • 财政年份:
    2013
  • 资助金额:
    $ 5万
  • 项目类别:
Relevance of the Route of Insulin Delivery to the Develpment of Hypoglycemia
胰岛素输送途径与低血糖发生的相关性
  • 批准号:
    8764640
  • 财政年份:
    2013
  • 资助金额:
    $ 5万
  • 项目类别:
Metformin and Muscle in Insulin-resistant Older Veterans
二甲双胍与胰岛素抵抗老年退伍军人的肌肉
  • 批准号:
    8967163
  • 财政年份:
    2013
  • 资助金额:
    $ 5万
  • 项目类别:
The role of HMGB-1 and innate immunity in promoting angiogenesis after ischemia
HMGB-1和先天免疫在促进缺血后血管生成中的作用
  • 批准号:
    8454426
  • 财政年份:
    2012
  • 资助金额:
    $ 5万
  • 项目类别:
The role of HMGB-1 and innate immunity in promoting angiogenesis after ischemia
HMGB-1和先天免疫在促进缺血后血管生成中的作用
  • 批准号:
    8650310
  • 财政年份:
    2012
  • 资助金额:
    $ 5万
  • 项目类别:
The role of HMGB-1 and innate immunity in promoting angiogenesis after ischemia
HMGB-1和先天免疫在促进缺血后血管生成中的作用
  • 批准号:
    8239893
  • 财政年份:
    2012
  • 资助金额:
    $ 5万
  • 项目类别:
Adipose Tissue Angiogenesis and Metabolic Disease
脂肪组织血管生成和代谢疾病
  • 批准号:
    8187450
  • 财政年份:
    2011
  • 资助金额:
    $ 5万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了